Audicus Omni 2 vs Otofonix Groove

The Audicus Omni 2 is a premium behind-the-ear OTC hearing aid priced at $1,898 that earned an A grade in our lab testing, placing it in the top 6% of the 65 OTC hearing aids we've evaluated. This two-time Expert's Choice Award winner (2023 and 2024) delivers consistently strong performance across multiple listening scenarios. In our testing, the Omni 2 demonstrated particular strength in speech clarity during quiet environments, scoring 4.2/5—a strong result that sits 1.38 points above the category average. Music streaming quality also impressed at 3.6/5, exceeding the category average by 1.68 points. Speech understanding in noisy environments scored 2.3/5, which is above the category average of 1.48 but represents mixed performance in absolute terms—meaning challenging noise situations may still prove difficult. The device offers flexible power options with both rechargeable and disposable batteries, and supports streaming from both iPhone and Android devices with hands-free capability. Feedback handling is excellent at 4.5/5, essentially matching the category average, while own-voice comfort scores a solid 3.0/5. The Audicus Omni 2 is best suited for consumers seeking a premium OTC option with strong everyday speech clarity and quality streaming capabilities. Those frequently in very noisy environments should set realistic expectations, though the device still outperforms most OTC competitors in these conditions.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.